Patent application number | Description | Published |
20140116250 | SORBENT ARTICLE FOR CO2 CAPTURE - A sorbent article having a substrate having porous channel walls defining open channels, and an organic-inorganic hybrid sorbent material distributed on a surface of the porous channel walls, wherein the sorbent material is derived from an amino-functionalized alkoxysilane and a polyamine, wherein the sorbent material is present in an amount equal to or greater than 10 g/l, wherein at least some of the sorbent material resides in the porous channel walls and forms CO | 05-01-2014 |
20140212467 | Antimicrobial Composite Material - The present disclosure is directed to an antimicrobial composite material, and more particularly to an antimicrobial composite material comprising particles having a metal or metal alloy core and a porous inorganic material shell, coatings including the antimicrobial composite material, and methods of making the same. In some embodiments, Cu—SiO | 07-31-2014 |
20150225572 | HIGH PERFORMANCE ANTIMICROBIAL COATING - Embodiments of various antimicrobial coatings that exhibit high antimicrobial performance are provided. In one or more embodiments, the antimicrobial coating includes a carrier and a plurality of copper particles dispersed in the carrier. The particles include a stable copper state of Cu | 08-13-2015 |
20150230476 | Antimicrobial Glass Compositions, Glasses and Polymeric Articles Incorporating The Same - Embodiments of the present invention pertain to antimicrobial glass compositions, glasses and articles. The articles include a glass, which may include a glass phase and a cuprite phase. In other embodiments, the glasses include as plurality of Cu | 08-20-2015 |
Patent application number | Description | Published |
20090110873 | Polymer Hybrid Membrane Structures - Hybrid membrane structures that include: an inorganic porous support that includes first and second ends, and a plurality of inner channels having surfaces defined by porous walls and extending through the support from the first to the second ends; optionally, one or more porous inorganic intermediate layers coating the inner channel surfaces; and a polymeric amine-containing membrane. | 04-30-2009 |
20090110907 | Membranes Based On Poly (Vinyl Alcohol-Co-Vinylamine) - Polymer membranes that include a crosslinked poly(vinyl alcohol-co-vinylamine), which membranes are non-porous or are porous with pores having a median pore size of 300 nm or less. Also disclosed are polymer membranes which include a crosslinked poly(vinyl alcohol-co-vinylamine) and which also include a second polyamine wherein the poly(vinyl alcohol-co-vinylamine) and the second polyamine are crosslinked with one another. | 04-30-2009 |
20100222489 | COPOLYMER COMPOSITION, MEMBRANE ARTICLE, AND METHODS THEREOF - A poly(amino-alcohol) membrane article, and a method for making and using the article, as defined herein. | 09-02-2010 |
20100300289 | POLY(AMINO-ALCOHOL)-SILICA HYBRID COMPOSITIONS AND MEMBRANES - The present invention provides a method for making a hybrid composition membrane comprising the steps of preparing a sol comprising at least one poly(amino-alcohol) and at least one alkoxy silane, casting the sol on a surface and drying the casted sol to form the hybrid composition membrane. The hybrid composition membrane may be used for capturing and separating CO | 12-02-2010 |
20100305289 | HYBRID COMPOSITION AND MEMBRANE BASED ON SILYLATED HYDROPHILIC POLYMER - The present invention provides a method for making an organic-inorganic hybrid composition membrane comprising the steps of preparing a sol comprising at lease one silylated polyamine, casting the sol onto a surface and drying the sol to form the organic-inorganic hybrid composition membrane. The hybrid composition membrane may be used for capturing and separating CO | 12-02-2010 |
20130012633 | HYBRID COMPOSITION AND MEMBRANE BASED ON SILYLATED HYDROPHILIC POLYMER - The present invention provides a method for making an organic-inorganic hybrid composition membrane comprising the steps of preparing a sol comprising at lease one silylated polyamine, casting the sol onto a surface and drying the sol to form the organic-inorganic hybrid composition membrane. The hybrid composition membrane may be used for capturing and separating CO | 01-10-2013 |
Patent application number | Description | Published |
20100129547 | WASHCOATING HIGH POROSITY CERAMIC SUBSTRATES - A method of washcoating a high porosity honeycomb substrate is described that involves contacting the channels of the honeycomb with a solution of a viscosity raising material for a time sufficient to fill the pores of the honeycomb with the solution and viscosity changing material. When the pores come into contact with a washcoat slurry, the pH of the slurry at the pore site is changed and the viscosity of the slurry is raised such that it cannot enter the pores. Viscosity raising materials include water soluble polyamines. In one embodiment the polyamine is polyethylenimine. Amino-containing compounds having a molecular weight in the range of 300 to 50,000 can be used in practicing the invention. | 05-27-2010 |
20110120305 | AMINO ACID SALT ARTICLES AND METHODS OF MAKING AND USING THEM - An article comprising a substrate; and an amino acid salt disposed on the substrate. The article may be useful, for example, in the removal of an acid gas component from a gas. | 05-26-2011 |
20110120306 | CARBOXYLIC ACID SALT ARTICLES AND METHODS OF MAKING AND USING THEM - An article comprising a substrate; and a carboxylic acid alkali salt disposed on the substrate, wherein the carboxylic acid alkali salt is derived from a carboxylic acid having at least one dissociation constant greater than or equal to 5. The article may be useful, for example, in the removal of an acid gas component from a gas. | 05-26-2011 |
20120216675 | Sorbent Articles for CO2 Capture - A sorbent article having a substrate having porous channel walls defining open channels, and an organic-inorganic hybrid sorbent material distributed on a surface of the porous channel walls, wherein the sorbent material is derived from an amino-functionalized alkoxysilane and a polyamine, wherein the sorbent material is present in an amount equal to or greater than 10 g/l, wherein at least some of the sorbent material resides in the porous channel walls and forms CO | 08-30-2012 |
20120272823 | Article for CO2 Capture Having Heat Exchange Capability - An article comprising a plurality of intersecting walls having outer surfaces that define a plurality of cells extending from one end to a second end, wherein the walls forming each cell in a first subset of cells are covered by a barrier layer to form a plurality of heat exchange flow channels, and wherein the walls forming each cell in a second subset of cells different from the first subset of cells, comprise a CO | 11-01-2012 |
20140271394 | IMPERMEABLE POLYMER COATING ON SELECTED HONEYCOMB CHANNEL SURFACES - Absorbent structures for CO | 09-18-2014 |
20140311341 | SORBENT COMPOSITIONS, SORBENT ARTICLES, METHODS FOR PREPARING SORBENT ARTICLES, AND METHODS FOR CAPTURING TARGET GASES USING THE SORBENT ARTICLES - Articles for capturing or separating a target gas from a gas stream may include a porous substrate such as a flexible sheet or mat, or a rigid ceramic monolith impregnated or coated with a sorbent composition. The sorbent composition may include a polyamine and a coexistent polymer chemically bonded to the polyamine. The polyamine may include a polyethylenimine. The coexistent polymer may include a polyurethane, a polyolefin-acrylic acid copolymer, or a combination thereof. The sorbent composition may be substantially less water-insoluble than compositions containing only a polyamine and may have high durability and good adsorption capacity for acidic target gases such as carbon dioxide. Methods for preparing the articles using aqueous polymer solutions are provided. Methods for capturing or separating target gases using the articles are provided. | 10-23-2014 |
Patent application number | Description | Published |
20120278038 | ESTIMATING MONTHLY HEATING OIL CONSUMPTION FROM FISCAL YEAR OIL CONSUMPTION DATA USING MULTIPLE REGRESSION AND HEATING DEGREE DAY DENSITY FUNCTION - Estimating monthly heating oil consumption of a building that uses heating oil and non-oil source of energy, may include separating by applying statistical models, yearly consumption of oil data associated with the building into base load oil consumption and space heating oil consumption. The separating may also include determining monthly base load oil consumption associated with the building. Monthly space heating consumption of oil may be estimated by applying a heating degree day density function to the space heating oil consumption. The monthly space heating consumption may be aggregated with the monthly base load oil consumption to estimate the monthly heating oil consumption. | 11-01-2012 |
20120278051 | ANOMALY DETECTION, FORECASTING AND ROOT CAUSE ANALYSIS OF ENERGY CONSUMPTION FOR A PORTFOLIO OF BUILDINGS USING MULTI-STEP STATISTICAL MODELING - Multi-step statistical modeling in one embodiment of the present disclosure enables anomaly detection, forecasting and/or root cause analysis of the energy consumption for a portfolio of buildings using multi-step statistical modeling. In one aspect, energy consumption data associated with a building, building characteristic data associated with the building, building operation and activities data associated with the building, and weather data are used to generate a variable based degree model. A base load factor, a heating coefficient and a cooling coefficient associated with the building and an error term are determined from the variable based degree model and used to generate a plurality of multivariate regression models. A time series model is generated for the error term to model seasonal factors which reflect monthly dependence on energy use and an auto-regressive integrated moving average model (ARIMA) which reflects temporal dependent patterns of the energy use. | 11-01-2012 |
20130046721 | CHANGE POINT DETECTION IN CAUSAL MODELING - Structural changes in causal relationship over time may be detected, for example, by a Markov switching vector autoregressive model that detects and infers the structural changes in the causal graphs. | 02-21-2013 |
Patent application number | Description | Published |
20090089021 | HUYGENS' BOX METHODOLOGY FOR SIGNAL INTEGRITY ANALYSIS - A method for performing a signal integrity analysis on an integrated circuit (IC) that includes a plurality of scatterers by dividing the scatterers into subgroups using a nested Huygens' equivalence principle algorithm and solving a set of equations realized thereby with a reduced coupling matrix. The method includes decomposing the IC design into a plurality of small non-overlapping circuit sub-domains, wherein each of the sub-domains is formed as a small, enclosed region. Each sub-domain is analyzed independently of the other sub-domains using only electric fields to represent the interactions of each sub-domains with the other sub-domains as equivalent currents on equivalent surfaces of the plurality of sub-domains. Neighboring equivalent sub-domains are grouped together to form larger sub-domains using equivalent currents on equivalent surfaces to represent the interactions of the sub-domains. The steps of analyzing and grouping the sub-domains are repeated until the grouping approaches a box comprising the entire domain, and that the domain interactions between every sub-domain have been analyzed. | 04-02-2009 |
20090144685 | DOUBLE-LAYER INTEGRAL USING A STATIC GREEN'S FUNCTION AND RECTANGULAR BASIS - The present invention a new closed-form double-layer integral for a rectangular basis. It is valid for both self integrals and non-self integrals. In general, the approach of the present invention contains only six (6) terms and is much simpler than indirect closed-form results, which has 24 terms. | 06-04-2009 |
20100161293 | HUYGENS' BOX METHODOLOGY FOR SIGNAL INTEGRITY ANALYSIS - A method for performing a signal integrity analysis on an integrated circuit (IC) that includes a plurality of scatterers by dividing the scatterers into subgroups using a nested Huygens' equivalence principle algorithm and solving a set of equations realized thereby with a reduced coupling matrix. The method includes decomposing the IC design into a plurality of small non-overlapping circuit sub-domains, wherein each of the sub-domains is formed as a small, enclosed region. Each sub-domain is analyzed independently of the other sub-domains using only electric fields to represent the interactions of each sub-domains with the other sub-domains as equivalent currents on equivalent surfaces of the plurality of sub-domains. Neighboring equivalent sub-domains are grouped together to form larger sub-domains using equivalent currents on equivalent surfaces to represent the interactions of the sub-domains. The steps of analyzing and grouping the sub-domains are repeated until the grouping approaches a box comprising the entire domain, and that the domain interactions between every sub-domain have been analyzed. | 06-24-2010 |
Patent application number | Description | Published |
20090275590 | (1-AZINONE)-SUBSTITUTED PYRIDOINDOLES - Substituted pyridoindoles for incorporation in pharmaceutical compositions employed in the treatment of various diseases correspond to formula (I) | 11-05-2009 |
20100105679 | 5-PYRIDINONE SUBSTITUTED INDAZOLES - Various 5-substituted 1-substituted indazoles are described, as are pharmaceutical compositions containing these compounds and methods of treatment of diseases using these compounds. Other embodiments are also described. | 04-29-2010 |
20100331339 | (1-AZINONE)-SUBSTITUTED PYRIDOINDOLES - Substituted pyridoindoles for incorporation in pharmaceutical compositions employed in the treatment of various diseases correspond to formula (I) | 12-30-2010 |
20110003738 | AZINONE-SUBSTITUTED AZAPOLYCYCLE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF - Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention. | 01-06-2011 |
20120058940 | AZINONE-SUBSTITUTED AZAPOLYCYCLE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF - Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention. | 03-08-2012 |
20130053382 | Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1) - The instant invention provides for compounds that inhibit PDK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting PDK1 activity by administering the compound to a patient in need of treatment of cancer. | 02-28-2013 |
20140179648 | Novel Heterocyclic Compounds as Bromodomain Inhibitors - The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy. | 06-26-2014 |
20140206696 | (1-AZINONE)-SUBSTITUTED PYRIDOINDOLES - Substituted pyridoindoles for incorporation in pharmaceutical compositions employed in the treatment of various diseases correspond to formula (I) | 07-24-2014 |
Patent application number | Description | Published |
20090170841 | Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders - The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease. | 07-02-2009 |
20120129860 | STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS - The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease. | 05-24-2012 |
20130210805 | QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS - This application provides for compounds of the formula Formula I or a pharmaceutically acceptable salt thereof, wherein the individual variables are defined herein, as well as processes to prepare these compounds, pharmaceutical compositions comprising the same and their use in treating disease state associated with the CRTH | 08-15-2013 |
20130253064 | STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS - The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease. | 09-26-2013 |
20130303517 | QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS - The invention provides certain quinoxalines and aza-quinoxalines of the Formula (I), and their pharmaceutically acceptable salts, wherein J | 11-14-2013 |
20150232476 | COMPOUNDS AND METHODS FOR PREVENTING, TREATING AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH - Disclosed herein are compounds, and pharmaceutical compositions that include such compounds, for preventing, treating, and/or protecting against sensory hair cell death. Methods of using the compounds, alone or in combination with other therapeutic agents, are also disclosed. | 08-20-2015 |
20150238497 | STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS - The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease. | 08-27-2015 |
Patent application number | Description | Published |
20120088181 | Chemical Durability Using Synergystic Mitigation Strategies - A fuel cell includes an ion conducting membrane having a first side and a second side. Characteristically, the ion conducting membrane has a sufficient amount of a stabilization agent and platinum to inhibit the loss of fluoride from the ion conducting membrane when compared to an ion conducting membrane having the same construction except for the presence of cerium ions. | 04-12-2012 |
20120122016 | Fuel Cell Durability Through Oxide Supported Precious Metals in Membrane - A fuel cell includes an anode, a cathode, and an ion conducting membrane interposed between the anode and cathode. The ion conducting membrane includes a base layer that has an ion conducting polymer and additive layer that has a metal supported on an oxide support, the oxide support scavenging hydroxyl radicals formed during fuel cell operation. | 05-17-2012 |
20120135332 | FUEL CELLS HAVING IMPROVED DURABILITY - A fuel cell or a fuel cell stack component comprises an active area and a non-active area. A peroxide decomposing metal compound or metal alloy is disposed in or on the non-active area of a fuel cell or a fuel cell component. The metal compound or alloy is capable of providing a peroxide decomposing metal species that can migrate from the non-active area to an active area of a fuel cell. A fuel cell or membrane electrode assembly having a peroxide decomposing metal compound or alloy disposed in its non-active area exhibits improved durability. | 05-31-2012 |
20120244452 | DIRECT CATALYST COATING ON FREE STANDING MICROPOROUS LAYER - Methods of making reinforced membrane electrode assemblies are described. Catalyst coated free standing microporous layers and reinforced membrane electrode assemblies are also described. | 09-27-2012 |
20130022895 | Membrane with Laminated Structure and Orientation Controlled Nanofiber Reinforcement Additives for Fuel Cells - An ion-conducting membrane for fuel cell applications a first layer including a first ion-conducting polymer and nanofibers dispersed therein. The first layer includes a first side and a second side. A second layer is disposed over the first side of the first layer and includes a second ion-conducting polymer without nanofibers. | 01-24-2013 |
20130130133 | Nanofiber Supported Catalysts As Membrane Additives For Improved Fuel Cell Durability - A fuel cell membrane and a method of making the same. The membrane includes at least one non-reinforced layer and at least one reinforced layer. Both layers include a proton-conductive ionomer, while the reinforced layer additionally includes nanofiber-supported catalyst that improve mechanical and chemical durability of the membrane. The nanofiber-supported catalyst is made up of structural fibers onto which an electrocatalyst is coated, deposited or otherwise formed. The structural nanofibers give increased strength and stiffness to the layers that include them, while the electrocatalyst helps to resist electrochemical degradation to the membranes that include them. Such a membrane may form the basis of a fuel cell's membrane electrode assembly. | 05-23-2013 |
20130157167 | ALTERNATE MATERIAL FOR ELECTRODE TOPCOAT - A reduced gas crossover fuel cell membrane and method of making. The fuel cell member includes an electrode layer with a catalyst and an electrochemically-active first ionomer and an overcoat layer disposed on the electrode layer. The overcoat layer is made of the same or different second ionomer relative to the first ionomer of the electrode layer with at least one reduced gas crossover characteristic. | 06-20-2013 |
20130236810 | Fuel Cell Durability By Orthogonally Oriented Anisotropic External Reinforce Layers - A fuel cell includes a proton exchange membrane having a first major side and a second major side. The membrane electrode assembly includes a first anisotropic reinforced layer having a first plurality of fiber preferentially oriented along a first direction, a second anisotropic reinforced layer having a second plurality of fiber preferentially oriented along a second direction, and a polymeric layer including a plurality of sulfonic acid groups. A cathode catalyst layer is disposed over the first major side of the proton exchange membrane while an anode catalyst layer is disposed over the second major side of the proton exchange membrane. An anode flow field plate is disposed over the anode catalyst layer and a cathode flow field plate is disposed over the cathode catalyst layer. | 09-12-2013 |
20140120458 | Direct Coated Membrane Electrode Assembly On External Reinforcement For Fuel Cells - Disclosed are methods for fabricating a reinforced membrane electrode assembly having one or more freestanding external reinforcement layers. The method comprises providing a freestanding external reinforcement layer, and depositing a catalyst solution and membrane solution onto at least a portion of the freestanding external reinforcement layer. | 05-01-2014 |
Patent application number | Description | Published |
20090298774 | Bifunctional Molecules for Inhibiting HIV Entry - Disclosed herein are bifunctional molecules which inhibit HIV entry into the target cell. Also disclosed are novel anti-HIV therapeutics for treatment of patients infected by HIV, including non-B and multi-drug resistant strains. | 12-03-2009 |
20100040631 | Combination Therapy of HIV Using Fusion/Entry Inhibitors Targeting GP41 - Provided herein are pharmaceutical compositions for the prophylactic and therapeutic treatment of HIV comprising combinations of HIV fusion/entry inhibitors with different target sites in HIV gp41 or different mechanisms of action. Also disclosed are methods of treating HIV infection by administering such compositions. | 02-18-2010 |
20100098724 | IMMUNOENHACER-LINKED OLIGOMERIC HIV VACCINES - Provided herein are immunogenic compositions comprising fusion proteins, the fusion proteins comprising lentivirus gp41 or a fragment thereof, a trimerization or oligomerization motif and an immunoenhancer that elicit potent and broad HIV neutralizing antibody responses in the immunized hosts. Also disclosed are methods of making and using the immunogenic compositions. | 04-22-2010 |
20100204120 | TRIMERIC HIV FUSION INHIBITORS FOR TREATING OR PREVENTING HIV INFECTION - Disclosed herein are trimeric polypeptide pharmaceutical compositions comprising three monomers, each monomer comprising a polypeptide having the amino acid sequence of the N-terminal heptad repeat (NHR or HR1) or C-terminal heptad repeat (CHR or HR2) of the transmembrane glycoprotein of human immunodeficiency virus (HIV) and a trimerization motif. | 08-12-2010 |
20100292324 | Multi-Substituted Diarylanilines as Non-Nucleoside HIV Reverse Transcriptase Inhibitors, and Preparation and Use Thereof - The present invention relates to multi-substituted m-diarylanilines or pharmaceutically acceptable salts thereof, wherein X, R | 11-18-2010 |
20110086058 | Immunopotentiator-Linked Oligomeric Influenza Immunogenic Compositions - Disclosed herein are immunogenic compositions for preventing infection with influenza viruses wherein the immunogenic compositions comprises an immunogen such as a hemagglutinin of an influenza virus, and an immunopotentiator such as an Fc fragment of human IgG and optionally a stabilization sequence. The immunogen is linked to the stabilization sequence which in turn is linked to the immunopotentiator. | 04-14-2011 |
20110269676 | BIFUNCTIONAL MOLECULES FOR INACTIVATING HIV AND BLOCKING HIV ENTRY - Disclosed herein are bifunctional molecules which inactivate human immunodeficiency virus (HIV) even before the virus attacks the target cell and inhibits HIV entry into the target cell. Also disclosed are novel anti-HIV therapeutics for treatment of patients infected by HIV. Further disclosed are methods for prophylaxis against HIV and treatment of HIV infection. | 11-03-2011 |
Patent application number | Description | Published |
20120100150 | Influenza Hemagglutinin-Specific Monoclonal Antibodies for Preventing and Treating Influenza Virus Infection - Disclosed herein are neutralizing antibodies with cross-neutralizing activity and cross-protective effects against divergent stains of influenza virus, which are specific for an epitope having at least 90% homology to amino acids +72-115 of the HA1 domain of H5N1 influenza virus hemagglutinin. | 04-26-2012 |
20150030607 | INFLUENZA HEMAGGLUTININ-SPECIFIC MONOCLONAL ANTIBODIES FOR PREVENTING AND TREATING INFLUENZA VIRUS INFECTION - Disclosed herein are neutralizing antibodies with cross-neutralizing activity and cross-protective effects against divergent stains of influenza virus, which are specific for an epitope having at least 90% homology to amino acids +72-115 of the HA1 domain of H5N1 influenza virus hemagglutinin. | 01-29-2015 |
20150306174 | Trimeric HIV Fusion Inhibitors for Treating or Preventing HIV Infection - Disclosed herein are trimeric polypeptide pharmaceutical compositions comprising three monomers, each monomer comprising a polypeptide having the amino acid sequence of the N-terminal heptad repeat (NHR or HR1) or C-terminal heptad repeat (CHR or HR2) of the transmembrane glycoprotein of human immunodeficiency virus (HIV) and a trimerization motif. | 10-29-2015 |
20160000900 | OLIGOMERIC INFLUENZA IMMUNOGENIC COMPOSITIONS - Embodiments are provided for network resource allocation considering user experience, satisfaction, and operator interest. An embodiment method by a network component for allocating network resources includes evaluating, for a user, a QoE for each flow of a plurality of flows in network traffic in according with a QoE model, and further evaluating, for an operator, a revenue associated with the flows in accordance with a revenue model. A plurality of priorities that correspond to the flows are calculated in accordance with the QoE for the user and the revenue for the operator. The method further includes identifying a flow of the flows with a highest value of the priorities, and allocating a network resource for the flow. In an embodiment, the QoE model is a satisfaction model that provides a measure of user satisfaction for each flow in accordance with a subscription or behavior class of the user. | 01-07-2016 |